Vanda Pharmaceuticals VNDA
NASDAQ VNDA
$5.43 +0.09 (+1.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vanda Pharmaceuticals (VNDA) Net Shares Issued and Repurchased (2010 - 2018)

Analysis

Vanda Pharmaceuticals (VNDA) Net Shares Issued and Repurchased (2010 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Vanda Pharmaceuticals 327.03 Mn 157.00 Mn 46.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 437,500.00
Dec 31, 2017 643,000.00
Mar 31, 2017 592,750.00
Dec 31, 2016 866,011.00
Mar 31, 2016 749,511.00
Dec 31, 2015 1.06 Mn
Mar 31, 2015 459,000.00
Dec 31, 2014 1.32 Mn
Mar 31, 2014 165,340.00
Dec 31, 2013 1.25 Mn
Mar 31, 2013 197,214.00
Dec 31, 2012 846,000.00
Dec 31, 2011 26,764.00
Dec 31, 2010 471,957.00